Exploring the Kidney-Brain Connection: Anxiety & Depression in Chronic Kidney Disease
Define anxiety and depression, and discuss prevalence among chronic kidney disease (CKD) patients. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Major Depressive Disorder In Chronic Kidney Disease
Major Depressive Disorder In Chronic Kidney Disease
Major Depressive Disorder In Chronic Kidney Disease
This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology. Read MoreMajor Depressive Disorder In Chronic Kidney Disease
This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology. Read MoreMajor Depressive Disorder In Chronic Kidney Disease
Major Depressive Disorder affects more than 260 million people worldwide. The reported prevalence of depression in patients with Chronic Kidney Disease (CKD) ranges from 20-65%. This presentation provides an overview… Read MoreMajor Depressive Disorder In Chronic Kidney Disease
Major Depressive Disorder affects more than 260 million people worldwide1. The reported prevalence of depression in patients with Chronic Kidney Disease (CKD) ranges from 20-65%2. This presentation provides an overview… Read MoreMajor Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an… Read MoreMajor Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an… Read MoreMajor Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an… Read MoreMajor Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an… Read MoreMajor Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology. Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
